Standard BioTools Inc
LAB1.380USD
-0.090-6.12%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
529.39MMarket Cap
LossP/E TTM
More Details of Standard BioTools Inc Company
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Standard BioTools Inc Info
Ticker SymbolLAB
Company nameStandard BioTools Inc
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Number of employees818
Security typeOrdinary Share
Fiscal year-endFeb 10
Address2 Tower Place
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone16502666000
Websitehttps://www.standardbio.com/
Ticker SymbolLAB
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Company Executives of Standard BioTools Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-23.01%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-23.01%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
10.46M
48.06%
Services and other revenue
6.09M
27.98%
Instruments
5.21M
23.96%
By RegionUSD
Name
Revenue
Proportion
Europe & Middle East & Africa (EMEA)
9.13M
41.94%
Americas
8.69M
39.93%
Asia-Pacific
3.94M
18.13%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
10.46M
48.06%
Services and other revenue
6.09M
27.98%
Instruments
5.21M
23.96%
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
The Vanguard Group, Inc.
4.47%
MAK Capital One, LLC
4.14%
Other
47.38%
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
The Vanguard Group, Inc.
4.47%
MAK Capital One, LLC
4.14%
Other
47.38%
Shareholder Types
Shareholders
Proportion
Hedge Fund
32.60%
Investment Advisor/Hedge Fund
27.75%
Investment Advisor
14.81%
Individual Investor
2.53%
Research Firm
0.66%
Venture Capital
0.57%
Bank and Trust
0.23%
Pension Fund
0.12%
Insurance Company
0.03%
Other
20.68%
Institutional Shareholding
Updated: Sun, Oct 5
Updated: Sun, Oct 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
2023Q3
265
53.37M
67.31%
-13.39M
2023Q2
273
51.56M
65.50%
-19.05M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Casdin Capital, LLC
77.06M
20.17%
+100.00K
+0.13%
Sep 09, 2025
Viking Global Investors LP
58.65M
15.35%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
21.79M
5.71%
-554.16K
-2.48%
Jun 30, 2025
The Vanguard Group, Inc.
16.93M
4.43%
-243.51K
-1.42%
Jun 30, 2025
MAK Capital One, LLC
5.60M
1.47%
+2.82M
+101.73%
Jun 30, 2025
Long Focus Capital Management LLC
10.07M
2.64%
+3.37M
+50.30%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.44M
1.95%
+235.68K
+3.27%
Jun 30, 2025
State Street Investment Management (US)
6.30M
1.65%
-57.83K
-0.91%
Jun 30, 2025
Hollow Brook Wealth Management, LLC
5.61M
1.47%
+56.93K
+1.03%
Jun 30, 2025
Morgan Stanley Investment Management Inc. (US)
5.36M
1.4%
-4.51M
-45.67%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.51%
ARK Genomic Revolution ETF
Proportion0.33%
iShares Micro-Cap ETF
Proportion0.07%
iShares Biotechnology ETF
Proportion0.04%
iShares Russell 2000 Value ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.02%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Fidelity MSCI Health Care Index ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Standard BioTools Inc?
The top five shareholders of Standard BioTools Inc are:
Casdin Capital, LLC holds 77.06M shares, accounting for 20.17% of the total shares.
Viking Global Investors LP holds 58.65M shares, accounting for 15.35% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 21.79M shares, accounting for 5.71% of the total shares.
The Vanguard Group, Inc. holds 16.93M shares, accounting for 4.43% of the total shares.
MAK Capital One, LLC holds 5.60M shares, accounting for 1.47% of the total shares.
Casdin Capital, LLC holds 77.06M shares, accounting for 20.17% of the total shares.
Viking Global Investors LP holds 58.65M shares, accounting for 15.35% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 21.79M shares, accounting for 5.71% of the total shares.
The Vanguard Group, Inc. holds 16.93M shares, accounting for 4.43% of the total shares.
MAK Capital One, LLC holds 5.60M shares, accounting for 1.47% of the total shares.
What are the top three shareholder types of Standard BioTools Inc?
The top three shareholder types of Standard BioTools Inc are:
Casdin Capital, LLC
Viking Global Investors LP
BlackRock Institutional Trust Company, N.A.
Casdin Capital, LLC
Viking Global Investors LP
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Standard BioTools Inc (LAB)?
As of 2025Q3, 324 institutions hold shares of Standard BioTools Inc, with a combined market value of approximately 277.96M, accounting for 72.29% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.39%.
What is the biggest source of revenue for Standard BioTools Inc?
In FY2025Q2, the Consumables business generated the highest revenue for Standard BioTools Inc, amounting to 10.46M and accounting for 48.06% of total revenue.
